Garching Innovation GmbH. Isis is not granting Alnylam any sublicense under the Co-Exclusive License Agreement dated October 18, 2004 among Isis, Alnylam and Garching Innovation GmbH.
Appears in 4 contracts
Samples: Strategic Collaboration And (Alnylam Pharmaceuticals, Inc.), License Agreement (Isis Pharmaceuticals Inc), Confidential Treatment (Isis Pharmaceuticals Inc)
